Medicare Enrolled

Dr. Joanna Lopez, MD

Internal Medicine · Miami, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
7500 SW 87TH AVE STE 200, Miami, FL 33173
3059130666
In practice since 2011 (14 years)
NPI: 1871889345 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lopez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lopez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lopez

Dr. Joanna Lopez is an internal medicine specialist in Miami, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Lopez performed 5,880 Medicare services across 419 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lopez received a total of $435,441 from 39 pharmaceutical and/or device companies across 581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lopez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 6% volume in FL $435,441 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 130677 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
5,880
Medicare services
Top 6% in FL for internal medicine
419
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~420 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Vedolizumab infusion (Entyvio) 5,400 $17 $52
Office visit, established patient (30-39 min) 113 $101 $348
Hospital follow-up visit, moderate complexity 86 $68 $237
Office visit, established patient (20-29 min) 55 $66 $237
Initial hospital admission, moderate complexity 51 $112 $455
Blood draw (venipuncture) 32 $8 $9
Hospital follow-up visit, low complexity 30 $44 $131
Colonoscopy with biopsy 24 $104 $1,500
Removal of polyps or growths of large bowel using an endoscope with mechanical snare 22 $232 $1,426
Upper GI endoscopy with biopsy 20 $102 $1,160
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 19 $55 $223
New patient office visit (45-59 min) 17 $137 $542
Initial hospital admission, high complexity 11 $151 $670
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
92.2% high complexity
0.7% medium
7.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$435,441
Total received (2018-2024)
Avg $62,206/year across 7 years
Top 0% in FL for internal medicine
39
Companies
581
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$423,020 (97.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,817 (1.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,605 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$178,649
2023
$90,635
2022
$103,202
2021
$36,849
2020
$16,846
2019
$8,505
2018
$755

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$121,519
Janssen Biotech, Inc.
$102,806
ABBVIE INC.
$93,888
Janssen Scientific Affairs, LLC
$55,130
E.R. Squibb & Sons, L.L.C.
$35,766
AbbVie Inc.
$10,136
Ferring Pharmaceuticals Inc.
$4,650
PFIZER INC.
$4,128
Amgen Inc.
$2,445
Pharmacosmos Therapeutics Inc.
$1,500
Celgene Corporation
$992
Celltrion USA Inc.
$666
AbbVie, Inc.
$450
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$243
Phathom Pharmaceuticals, Inc.
$117
Daiichi Sankyo Inc.
$115
PENTAX of America, Inc.
$112
RedHill Biopharma Inc.
$92
Gilead Sciences, Inc.
$86
GENZYME CORPORATION
$82
INTERCEPT PHARMACEUTICALS, INC.
$47
Intercept Pharmaceuticals, Inc.
$45
Merck Sharp & Dohme Corporation
$43
Regeneron Healthcare Solutions, Inc.
$38
Allergan, Inc.
$38
Endo Pharmaceuticals Inc.
$36
Shire North American Group Inc
$35
Ipsen Biopharmaceuticals, Inc
$31
AIMMUNE THERAPEUTICS, INC.
$25
Ethicon US, LLC
$24
Lilly USA, LLC
$23
EVOKE PHARMA, INC.
$20
Concordia Pharmaceuticals Inc.
$19
VIVUS LLC
$18
Shionogi Inc
$17
UCB, Inc.
$17
Braintree Laboratories, Inc.
$16
Tepha Inc
$14
Synergy Pharmaceuticals Inc
$13
Top 3 companies account for 73.1% of total payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Aemcolo · CapsoCam Plus · Cimzia · Creon · DIFICID · DONNATAL · DUPIXENT · ENTYVIO · Entyvio · Epclusa · GATTEX · GIMOTI · GalaFLEX · HUMIRA · Humira · INFLECTRA · INJECTAFER · IQIRVO · LINX Reflux Management System · LINZESS · MOTEGRITY · MOTOFEN · Monoferric · Mulpleta · NASCOBAL · OCALIVA · PANCREAZE · REBYOTA · REMICADE · RINVOQ · SKYRIZI · STELARA · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · XIFAXANIBSD · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in FL.

Equivalent to $7,405 per 100 Medicare services performed
Looking for an internal medicine specialist in Miami?
Compare internal medicine physicians in the Miami area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,908
Per 100K population
71.1
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lopez is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), with speaking/promotional industry engagement in the top 0% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lopez experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Lopez performed 5,400 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lopez receive payments from pharmaceutical companies?
Yes. Dr. Lopez received a total of $435,441 from 39 companies across 581 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lopez's costs compare to other internal medicine physicians in Miami?
Dr. Lopez's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lopez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →